Investors & Media

SEC Filing Details

Document Details

Form
Filing Date
Oct 4, 2018
Document Date
Oct 2, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Sangamo Therapeutics, Inc.
Issuer
SANGAMO THERAPEUTICS, INC
Filer
Boissel Stephane